These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12006394)

  • 1. Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study.
    Tai ES; Demissie S; Cupples LA; Corella D; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):805-10. PubMed ID: 12006394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.
    Robitaille J; Brouillette C; Houde A; Lemieux S; Pérusse L; Tchernof A; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(9):482-489. PubMed ID: 15309680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study.
    Tai ES; Corella D; Demissie S; Cupples LA; Coltell O; Schaefer EJ; Tucker KL; Ordovas JM;
    J Nutr; 2005 Mar; 135(3):397-403. PubMed ID: 15735069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study.
    Russo GT; Meigs JB; Cupples LA; Demissie S; Otvos JD; Wilson PW; Lahoz C; Cucinotta D; Couture P; Mallory T; Schaefer EJ; Ordovas JM
    Atherosclerosis; 2001 Sep; 158(1):173-81. PubMed ID: 11500189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia.
    Vohl MC; Lepage P; Gaudet D; Brewer CG; Bétard C; Perron P; Houde G; Cellier C; Faith JM; Després JP; Morgan K; Hudson TJ
    J Lipid Res; 2000 Jun; 41(6):945-52. PubMed ID: 10828087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
    Yilmaz-Aydogan H; Kurnaz O; Kucukhuseyin O; Akadam-Teker B; Kurt O; Eronat AP; Tekeli A; Bugra Z; Ozturk O
    Gene; 2013 Jul; 523(1):20-6. PubMed ID: 23583468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
    Flavell DM; Jamshidi Y; Hawe E; Pineda Torra I; Taskinen MR; Frick MH; Nieminen MS; Kesäniemi YA; Pasternack A; Staels B; Miller G; Humphries SE; Talmud PJ; Syvänne M
    Circulation; 2002 Mar; 105(12):1440-5. PubMed ID: 11914252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
    Tai ES; Collins D; Robins SJ; O'Connor JJ; Bloomfield HE; Ordovas JM; Schaefer EJ; Brousseau ME
    Atherosclerosis; 2006 Jul; 187(1):153-60. PubMed ID: 16221474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic influences on lipid metabolism trait variability within the Stanislas Cohort.
    Pallaud C; Gueguen R; Sass C; Grow M; Cheng S; Siest G; Visvikis S
    J Lipid Res; 2001 Nov; 42(11):1879-90. PubMed ID: 11714857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.
    Caron-Dorval D; Paquet P; Paradis AM; Rudkowska I; Lemieux S; Couture P; Vohl MC
    J Nutrigenet Nutrigenomics; 2008; 1(4):205-12. PubMed ID: 19776627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determination of plasma lipids and insulin in the Czech population.
    Hubacek JA; Waterworth DM; Poledne R; Pitha J; Skodová Z; Humphries SE; Talmud PJ
    Clin Biochem; 2001 Mar; 34(2):113-8. PubMed ID: 11311220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil.
    Bossé Y; Pascot A; Dumont M; Brochu M; Prud'homme D; Bergeron J; Després JP; Vohl MC
    Genet Med; 2002; 4(4):311-5. PubMed ID: 12172398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
    Jamshidi Y; Flavell DM; Hawe E; MacCallum PK; Meade TW; Humphries SE
    Atherosclerosis; 2002 Jul; 163(1):183-92. PubMed ID: 12048138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat.
    López-Miranda J; Jansen S; Ordovas JM; Salas J; Marín C; Castro P; Ostos MA; Cruz G; López-Segura F; Blanco A; Jiménez-Perepérez J; Pérez-Jiménez F
    Am J Clin Nutr; 1997 Jul; 66(1):97-103. PubMed ID: 9209175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
    Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
    Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study.
    Corella D; Tucker K; Lahoz C; Coltell O; Cupples LA; Wilson PW; Schaefer EJ; Ordovas JM
    Am J Clin Nutr; 2001 Apr; 73(4):736-45. PubMed ID: 11273848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II.
    Jansen H; Chu G; Ehnholm C; Dallongeville J; Nicaud V; Talmud PJ
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):303-8. PubMed ID: 9974411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
    Skogsberg J; McMahon AD; Karpe F; Hamsten A; Packard CJ; Ehrenborg E;
    J Intern Med; 2003 Dec; 254(6):597-604. PubMed ID: 14641801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.